About Bonraybio
Bonraybio is a company based in Taichung (Taiwan) founded in 2016. It operates as a HealthTech. Bonraybio offers products and services including LensHooke, Sperm Routine Testing Equipment, Sperm DNA Fragmentation Testing, and Sperm Washing Device. Bonraybio operates in a competitive market with competitors including Exseed Health, Sandstone Diagnostics, Spermosens, Swimcount and Human Biogenesis, among others.
- Headquarter Taichung, Taiwan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bonraybio Co., Ltd.
-
Annual Revenue
$222.88 M39.61as on Dec 31, 2024
-
Net Profit
$68.36 M165.75as on Dec 31, 2024
-
EBITDA
$72.78 M127.54as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bonraybio
Bonraybio offers a comprehensive portfolio of products and services, including LensHooke, Sperm Routine Testing Equipment, Sperm DNA Fragmentation Testing, and Sperm Washing Device.
Innovative device for sperm detection and analysis used.
Equipment designed for routine sperm quality testing purposes.
Advanced testing equipment for sperm DNA fragmentation analysis.
Device used for sperm washing in fertility treatments.
Funding Insights of Bonraybio
Detailed funding history for Bonraybio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bonraybio
Investment portfolio details for Bonraybio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bonraybio
Detailed financials for Bonraybio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bonraybio Comparisons
Peer comparison for Bonraybio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bonraybio
Bonraybio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exseed Health, Sandstone Diagnostics, Spermosens, Swimcount and Human Biogenesis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a home-based sperm test kit
|
|
| Locked | Locked | Locked |
Provides rapid tests for accurate sperm count diagnostics.
|
|
| Locked | Locked | Locked |
Spermosens is focused on developing male-factor infertility diagnostic devices.
|
|
| Locked | Locked | Locked |
-
|
|
| Locked | Locked | Locked |
Provider of reproductive health services and solutions
|
Detailed competitors of Bonraybio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bonraybio
Complete news archive for Bonraybio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bonraybio
Bonraybio was founded in 2016.
Bonraybio is headquartered in Taichung, Taiwan.
Bonraybio is engaged in the development of high-precision and user-friendly medical equipment aimed at improving global reproductive healthcare quality. The company specializes in solutions for male infertility, addressing a critical gap in reproductive health technology. Products such as LensHooke, sperm routine testing equipment, sperm DNA fragmentation testing devices, and sperm washing devices are offered. The focus is on enhancing fertility outcomes in response to global demographic challenges like aging populations and rising infertility rates. Operations are based in Taiwan, with a mission to support healthcare providers worldwide.
Bonraybio's top competitors include Spermosens, Exseed Health and Swimcount.
Bonraybio offers LensHooke, Sperm Routine Testing Equipment, Sperm DNA Fragmentation Testing, and Sperm Washing Device.